Compared with the cells treated with PBS that exhibited a nominal height of 1869±51 nm, the cells treated with either AGE-HSA or CML-has exhibited a significantly reduced height (1614±58 and 1740±49 nm, respectively). This evidence concerns the gene ALB and chronic myelogenous leukemia, BCR-ABL1 positive.